Following the recent post on all swine flu stocks and other non-stock swine flu investments and how they stand to benefit or suffer under various scenarios, I’ve been keeping my eye on Novavax (NVAX) news especially. Today, a series of interviews were provided by the Novavax CEO Rahul Singhvi to discuss the swine flu vaccine [...]
Posts tagged as:
